SCHEMBL27352017

SCHEMBL27352017

COC(=O)C(N=N)(N=N)N=N

nearest known ligand 0.37

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
DGAT1 O75907 1/20 0.37
KCNN4 O15554 1/20 0.33
ALDH1A1 P00352 1/20 0.33
SRC P12931 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28325018 0.74 DGAT1 (0.44) DGAT1
SCHEMBL27354793 0.72 ALDH1A1 (0.42) ALDH1A1
SCHEMBL27977690 0.72 MEN1 (0.40)
SCHEMBL17213480 0.69 DGAT1 (0.35) DGAT1
SCHEMBL27977694 0.69 HCAR2 (0.36) ALDH1A1
SCHEMBL1527282 0.67
Ammonia Solution, Strong SCHEMBL7639328 0.67 DGAT1 (0.70) DGAT1KCNN4ALDH1A1SRC
Ammonia Solution, Strong SCHEMBL243818 0.67
SCHEMBL8096308 0.65 DGAT1 (0.46) DGAT1KCNN4ALDH1A1SRC
SCHEMBL4672716 0.65

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110066273-A A kind of single arylpyrimidines HIV-1 reverse transcriptase inhibitor of the ring containing triazole and the preparation method and application thereof 山东大学 2019-07-30 CN claimed
CN-110483220-A A kind of NEW TYPE OF COMPOSITE solid propellant and preparation method thereof and processing method BEIJING INSTITUTE TECH 2019-11-22 CN disclosed
CN-110483665-A A kind of preparation method of end triazolyl polybutadiene BEIJING INSTITUTE TECH 2019-11-22 CN disclosed
CN-110066273-A A kind of single arylpyrimidines HIV-1 reverse transcriptase inhibitor of the ring containing triazole and the preparation method and application thereof 山东大学 2019-07-30 CN disclosed
CN-109641911-A Seco- cyclopropyl pyrrolo-indole compound and its antibody-drug conjugates and preparation and application 百时美施贵宝公司 2019-04-16 CN disclosed
CN-109369623-A 1,2,3 triazole diaryl pyrimidine derivatives of a kind of substitution and the preparation method and application thereof 山东大学 2019-02-22 CN disclosed
CN-109153643-A Substituted indole MCL-1 inhibitors 范德比尔特大学 2019-01-04 CN disclosed
CN-105992766-A Pyrrolo [3,2-C ] pyridine derivatives as TLR inhibitors 武田药品工业株式会社 2016-10-05 CN disclosed
CN-104003983-B Containing the substituted bis-heterocyclic compounds of phenylseleno and preparation and application thereof 浙江工业大学 2016-08-17 CN disclosed
CN-105682655-A Antimicrobial compounds 阿克塞利亚制药公司 2016-06-15 CN disclosed
CN-1167681-C Condensed indoline derivatives and their use as 5HT, in particular 5HT2C receptor ligands О 2004-09-22 CN disclosed
CN-1134440-C 4-oxo-3,5-dihydro-4H-pyridazino [4,5-b]-indole-1-acetamide derivatives, their prepn. and their application in therapy �����ʩ���عɷݹ�˾ 2004-01-14 CN disclosed
CN-1395565-A Indole derivatives as MCP-1 receptor antagonists ASTRAZENECA AB (SE) 2003-02-05 CN disclosed
CN-1379761-A Fused indoline derivatives and their use as 5HT, in particular 5HT2C, receptor ligands VERNALIS RESAERCH LTD (GB) 2002-11-13 CN disclosed
CN-1351591-A Anti-inflammatory indole derivatives ASTRAZENECA AB (SE) 2002-05-29 CN disclosed
CN-1077572-C Substituted bisindolylmaleimides for inhibition of cell proliferation HOFFMANN LA ROCHE (CH) 2002-01-09 CN disclosed
CN-1061341-C 1-amino-ethylindole-derivatives HOFFMANN LA ROCHE (CH) 2001-01-31 CN disclosed
CN-1265108-A 4-oxo-3,5-dihydro-4H-pyridazino [4,5-b]-indole-1-acetamide derivatives, their prepn. and their application in therapy SANOFI SYNTHELABO (FR) 2000-08-30 CN disclosed
CN-1226249-A Substituted bisindolylmaleimides for inhibition of cell proliferation HOFFMANN LA ROCHE (CH) 1999-08-18 CN disclosed
CN-1105988-A 1-amino-ethylindole-derivatives HOFFMANN LA ROCHE (CH) 1995-08-02 CN disclosed